Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition

The BTK inhibitor ibrutinib is used to treat chronic lymphocytic leukaemia, however some patients develop resistance to the drug. Here, the authors use genomic analyses to examine the clonal evolution of 5 patients that develop resistance to ibrutinib.

Guardado en:
Detalles Bibliográficos
Autores principales: Jan A. Burger, Dan A. Landau, Amaro Taylor-Weiner, Ivana Bozic, Huidan Zhang, Kristopher Sarosiek, Lili Wang, Chip Stewart, Jean Fan, Julia Hoellenriegel, Mariela Sivina, Adrian M. Dubuc, Cameron Fraser, Yulong Han, Shuqiang Li, Kenneth J. Livak, Lihua Zou, Youzhong Wan, Sergej Konoplev, Carrie Sougnez, Jennifer R. Brown, Lynne V. Abruzzo, Scott L. Carter, Michael J. Keating, Matthew S. Davids, William G. Wierda, Kristian Cibulskis, Thorsten Zenz, Lillian Werner, Paola Dal Cin, Peter Kharchencko, Donna Neuberg, Hagop Kantarjian, Eric Lander, Stacey Gabriel, Susan O’Brien, Anthony Letai, David A. Weitz, Martin A. Nowak, Gad Getz, Catherine J. Wu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/31a1991cd4d64583af26755ec24a7d52
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:31a1991cd4d64583af26755ec24a7d52
record_format dspace
spelling oai:doaj.org-article:31a1991cd4d64583af26755ec24a7d522021-12-02T16:49:27ZClonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition10.1038/ncomms115892041-1723https://doaj.org/article/31a1991cd4d64583af26755ec24a7d522016-05-01T00:00:00Zhttps://doi.org/10.1038/ncomms11589https://doaj.org/toc/2041-1723The BTK inhibitor ibrutinib is used to treat chronic lymphocytic leukaemia, however some patients develop resistance to the drug. Here, the authors use genomic analyses to examine the clonal evolution of 5 patients that develop resistance to ibrutinib.Jan A. BurgerDan A. LandauAmaro Taylor-WeinerIvana BozicHuidan ZhangKristopher SarosiekLili WangChip StewartJean FanJulia HoellenriegelMariela SivinaAdrian M. DubucCameron FraserYulong HanShuqiang LiKenneth J. LivakLihua ZouYouzhong WanSergej KonoplevCarrie SougnezJennifer R. BrownLynne V. AbruzzoScott L. CarterMichael J. KeatingMatthew S. DavidsWilliam G. WierdaKristian CibulskisThorsten ZenzLillian WernerPaola Dal CinPeter KharchenckoDonna NeubergHagop KantarjianEric LanderStacey GabrielSusan O’BrienAnthony LetaiDavid A. WeitzMartin A. NowakGad GetzCatherine J. WuNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-13 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jan A. Burger
Dan A. Landau
Amaro Taylor-Weiner
Ivana Bozic
Huidan Zhang
Kristopher Sarosiek
Lili Wang
Chip Stewart
Jean Fan
Julia Hoellenriegel
Mariela Sivina
Adrian M. Dubuc
Cameron Fraser
Yulong Han
Shuqiang Li
Kenneth J. Livak
Lihua Zou
Youzhong Wan
Sergej Konoplev
Carrie Sougnez
Jennifer R. Brown
Lynne V. Abruzzo
Scott L. Carter
Michael J. Keating
Matthew S. Davids
William G. Wierda
Kristian Cibulskis
Thorsten Zenz
Lillian Werner
Paola Dal Cin
Peter Kharchencko
Donna Neuberg
Hagop Kantarjian
Eric Lander
Stacey Gabriel
Susan O’Brien
Anthony Letai
David A. Weitz
Martin A. Nowak
Gad Getz
Catherine J. Wu
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
description The BTK inhibitor ibrutinib is used to treat chronic lymphocytic leukaemia, however some patients develop resistance to the drug. Here, the authors use genomic analyses to examine the clonal evolution of 5 patients that develop resistance to ibrutinib.
format article
author Jan A. Burger
Dan A. Landau
Amaro Taylor-Weiner
Ivana Bozic
Huidan Zhang
Kristopher Sarosiek
Lili Wang
Chip Stewart
Jean Fan
Julia Hoellenriegel
Mariela Sivina
Adrian M. Dubuc
Cameron Fraser
Yulong Han
Shuqiang Li
Kenneth J. Livak
Lihua Zou
Youzhong Wan
Sergej Konoplev
Carrie Sougnez
Jennifer R. Brown
Lynne V. Abruzzo
Scott L. Carter
Michael J. Keating
Matthew S. Davids
William G. Wierda
Kristian Cibulskis
Thorsten Zenz
Lillian Werner
Paola Dal Cin
Peter Kharchencko
Donna Neuberg
Hagop Kantarjian
Eric Lander
Stacey Gabriel
Susan O’Brien
Anthony Letai
David A. Weitz
Martin A. Nowak
Gad Getz
Catherine J. Wu
author_facet Jan A. Burger
Dan A. Landau
Amaro Taylor-Weiner
Ivana Bozic
Huidan Zhang
Kristopher Sarosiek
Lili Wang
Chip Stewart
Jean Fan
Julia Hoellenriegel
Mariela Sivina
Adrian M. Dubuc
Cameron Fraser
Yulong Han
Shuqiang Li
Kenneth J. Livak
Lihua Zou
Youzhong Wan
Sergej Konoplev
Carrie Sougnez
Jennifer R. Brown
Lynne V. Abruzzo
Scott L. Carter
Michael J. Keating
Matthew S. Davids
William G. Wierda
Kristian Cibulskis
Thorsten Zenz
Lillian Werner
Paola Dal Cin
Peter Kharchencko
Donna Neuberg
Hagop Kantarjian
Eric Lander
Stacey Gabriel
Susan O’Brien
Anthony Letai
David A. Weitz
Martin A. Nowak
Gad Getz
Catherine J. Wu
author_sort Jan A. Burger
title Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
title_short Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
title_full Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
title_fullStr Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
title_full_unstemmed Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
title_sort clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to btk inhibition
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/31a1991cd4d64583af26755ec24a7d52
work_keys_str_mv AT janaburger clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT danalandau clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT amarotaylorweiner clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT ivanabozic clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT huidanzhang clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT kristophersarosiek clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT liliwang clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT chipstewart clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT jeanfan clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT juliahoellenriegel clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT marielasivina clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT adrianmdubuc clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT cameronfraser clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT yulonghan clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT shuqiangli clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT kennethjlivak clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT lihuazou clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT youzhongwan clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT sergejkonoplev clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT carriesougnez clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT jenniferrbrown clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT lynnevabruzzo clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT scottlcarter clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT michaeljkeating clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT matthewsdavids clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT williamgwierda clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT kristiancibulskis clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT thorstenzenz clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT lillianwerner clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT paoladalcin clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT peterkharchencko clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT donnaneuberg clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT hagopkantarjian clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT ericlander clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT staceygabriel clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT susanobrien clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT anthonyletai clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT davidaweitz clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT martinanowak clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT gadgetz clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
AT catherinejwu clonalevolutioninpatientswithchroniclymphocyticleukaemiadevelopingresistancetobtkinhibition
_version_ 1718383326107009024